Literature DB >> 18363012

Clinics in diagnostic imaging (121). Gallbladder adenomyomatosis.

Y Poonam1, S Ashu, G Rohini.   

Abstract

Adenomyomatosis of the gallbladder is a condition of benign hyperplasia of unknown aetiology, characterised by local or diffuse thickening of the muscular layer, with invagination of the epithelium, forming Rokitansky-Aschoff sinuses. Magnetic resonance imaging features are specific and help in the definitive diagnosis of this condition. A 50-year-old obese woman presented with episodic pain in the right hypochondrium. Ultrasonography, computed tomography and magnetic resonance imaging showed typical features of adenomyomatosis, which was subsequently confirmed by laparoscopic cholecystectomy.

Entities:  

Mesh:

Year:  2008        PMID: 18363012

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  4 in total

1.  The cholecystokin provocation HIDA test: recreation of symptoms is superior to ejection fraction in predicting medium-term outcomes.

Authors:  Gareth Morris-Stiff; Gavin Falk; Laurel Kraynak; Steven Rosenblatt
Journal:  J Gastrointest Surg       Date:  2010-09-08       Impact factor: 3.452

2.  An unusual association of diffuse adenomyomatosis with dysplastic adenoma in chronic calculous cholecystitis: case presentation.

Authors:  Isidoro Di Carlo; Adriana Toro; Elia Pulvirenti; Monica Zisa; Antonio Galia
Journal:  BMC Gastroenterol       Date:  2010-04-27       Impact factor: 3.067

Review 3.  Pathogenesis of gallbladder adenomyomatosis and its relationship with early-stage gallbladder carcinoma: an overview.

Authors:  Liwei Pang; Yan Zhang; Yuwen Wang; Jing Kong
Journal:  Braz J Med Biol Res       Date:  2018-05-21       Impact factor: 2.590

4.  A comparative study of clinicopathological features between chronic cholecystitis patients with and without Helicobacter pylori infection in gallbladder mucosa.

Authors:  Di Zhou; Wen-bin Guan; Jian-dong Wang; Yong Zhang; Wei Gong; Zhi-wei Quan
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.